Safety and Efficacy of Sufentanil NanoTab for Management of Acute Pain Following Bunionectomy

Completed · Phase 2 · Has a placebo group

Conditions studied: Acute Pain

In brief

This is a dose-finding study to determine if the sublingual administration of the Sufentanil NanoTab is safe and effective in the treatment of post-operative pain.

Key facts

Study ID

NCT01710345

Run by

Talphera, Inc

People needed

101

Starts

2012-10-01

Expected to finish

2013-02-01

Last updated by the study team

2015-01-26

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patients scheduled for bunion surgery

You may not qualify if…

• daily opioid use
• drug or alcohol abuse
• pregnant or breastfeeding women

Where it is running

• Lotus Clinical Research — Pasadena, California, United States
• Jean Brown Research — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.